Pregled bibliografske jedinice broj: 1133412
Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases
Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases // Applied Immunohistochemistry & Molecular Morphology, 24 (2016), 7; 521-530 doi:10.1097/pai.0000000000000213 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 1133412 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Molecular Genetic Alterations in Renal Cell
Carcinomas With Tubulocystic Pattern:
Tubulocystic Renal Cell Carcinoma, Tubulocystic
Renal Cell Carcinoma With Heterogenous Component
and Familial Leiomyomatosis-associated Renal Cell
Carcinoma. Clinicopathologic and Molecular
Genetic Analysis of 15 Cases
Autori
Ulamec, Monika ; Skenderi, Faruk ; Zhou, Ming ; Krušlin, Božo ; Martínek, Petr ; Grossmann, Petr ; Peckova, Kvetoslava ; Alvarado-Cabrero, Isabel ; Kalusova, Kristyna ; Kokoskova, Bohuslava ; Rotterova, Pavla ; Hora, Milan ; Daum, Ondrej ; Dubova, Magdalena ; Bauleth, Kevin ; Slouka, David ; Sperga, Maris ; Davidson, Whitney ; Rychly, Boris ; Perez Montiel, Delia ; Michal, Michal ; Hes, Ondrej
Izvornik
Applied Immunohistochemistry & Molecular Morphology (1541-2016) 24
(2016), 7;
521-530
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
kidney ; tubulocystic renal cell carcinoma ; papillary renal cell carcinoma ; hereditary leiomyomatosis-associated renal cell carcinoma ; chromosomal aberration
Sažetak
The characteristic morphologic spectrum of tubulocystic renal cell carcinoma (TC-RCC) may include areas resembling papillary RCC (PRCC). Our study includes 15 RCCs with tubulocystic pattern: 6 TC-RCCs, 1 RCC-high grade with tubulocystic architecture, 5 TC-RCCs with foci of PRCC, 2 with high-grade RCC (HGRCC) not otherwise specified, and 1 with a clear cell papillary RCC/renal angiomyoadenomatous tumor-like component. We analyzed aberrations of chromosomes 7, 17, and Y ; mutations of VHL and FH genes ; and loss of heterozygosity at chromosome 3p. Genetic analysis was performed separately in areas of classic TC-RCC and in those with other histologic patterns. The TC-RCC component demonstrated disomy of chromosome 7 in 9/15 cases, polysomy of chromosome 17 in 7/15 cases, and loss of Y in 1 case. In the PRCC component, 2/3 analyzable cases showed disomy of chromosome 7 and polysomy of chromosome 17 with normal Y. One case with focal HGRCC exhibited only disomy 7, whereas the case with clear cell papillary RCC/renal angiomyoadenomatous tumor-like pattern showed polysomies of 7 and 17, mutation of VHL, and loss of heterozygosity 3p. FH gene mutation was identified in a single case with an aggressive clinical course and predominant TC-RCC pattern. The following conclusions were drawn: (1) TC-RCC demonstrates variable status of chromosomes 7, 17, and Y even in cases with typical/uniform morphology. (2) The biological nature of PRCC/HGRCC-like areas within TC-RCC remains unclear. Our data suggest that heterogenous TC- RCCs may be associated with an adverse clinical outcome. (3) Hereditary leiomyomatosis-associated RCC can be morphologically indistinguishable from “high-grade” TC-RCC ; therefore, in TC-RCC with high-grade features FH gene status should be tested.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE